 Ruta Rao
Concepts (58)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 5 | 2012 | 427 | 0.900 |
Why?
| | Tamoxifen | 2 | 2012 | 27 | 0.620 |
Why?
| | Aromatase Inhibitors | 1 | 2012 | 10 | 0.510 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2012 | 21 | 0.510 |
Why?
| | Receptors, Progesterone | 1 | 2010 | 36 | 0.460 |
Why?
| | Postmenopause | 1 | 2010 | 66 | 0.450 |
Why?
| | Receptors, Estrogen | 1 | 2010 | 55 | 0.450 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 408 | 0.360 |
Why?
| | Dry Eye Syndromes | 1 | 2006 | 1 | 0.350 |
Why?
| | Cyclosporine | 1 | 2006 | 19 | 0.340 |
Why?
| | Graft vs Host Disease | 1 | 2006 | 45 | 0.330 |
Why?
| | Immunosuppressive Agents | 1 | 2006 | 167 | 0.300 |
Why?
| | Chemotherapy, Adjuvant | 2 | 2012 | 110 | 0.240 |
Why?
| | Antineoplastic Agents | 2 | 2009 | 314 | 0.150 |
Why?
| | Prospective Studies | 2 | 2010 | 1809 | 0.130 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2012 | 11 | 0.130 |
Why?
| | Ovariectomy | 1 | 2012 | 26 | 0.130 |
Why?
| | Medication Adherence | 1 | 2012 | 87 | 0.120 |
Why?
| | Night Blindness | 1 | 2010 | 2 | 0.120 |
Why?
| | Fenretinide | 1 | 2010 | 5 | 0.120 |
Why?
| | Female | 6 | 2012 | 17657 | 0.110 |
Why?
| | Radiodermatitis | 1 | 2009 | 4 | 0.100 |
Why?
| | Taxoids | 1 | 2009 | 16 | 0.100 |
Why?
| | Double-Blind Method | 1 | 2010 | 541 | 0.100 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 382 | 0.100 |
Why?
| | Brachytherapy | 1 | 2009 | 64 | 0.100 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2008 | 4 | 0.100 |
Why?
| | Genes, erbB-2 | 1 | 2008 | 8 | 0.100 |
Why?
| | Antigens, Neoplasm | 1 | 2008 | 56 | 0.100 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2007 | 7 | 0.090 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2007 | 8 | 0.090 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2007 | 14 | 0.090 |
Why?
| | Receptor, ErbB-2 | 1 | 2007 | 49 | 0.090 |
Why?
| | Tears | 1 | 2006 | 1 | 0.090 |
Why?
| | Muramidase | 1 | 2006 | 2 | 0.090 |
Why?
| | Administration, Topical | 1 | 2006 | 26 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2008 | 245 | 0.080 |
Why?
| | Visual Acuity | 1 | 2006 | 47 | 0.080 |
Why?
| | Humans | 6 | 2012 | 29841 | 0.080 |
Why?
| | Antibodies, Monoclonal | 1 | 2007 | 309 | 0.080 |
Why?
| | Middle Aged | 3 | 2010 | 11053 | 0.080 |
Why?
| | Follow-Up Studies | 1 | 2010 | 2017 | 0.070 |
Why?
| | Adult | 2 | 2010 | 9591 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2010 | 5016 | 0.050 |
Why?
| | Treatment Outcome | 1 | 2006 | 3788 | 0.040 |
Why?
| | Aged | 1 | 2010 | 9833 | 0.040 |
Why?
| | Mastectomy, Segmental | 1 | 2009 | 33 | 0.030 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2008 | 12 | 0.020 |
Why?
| | Gene Dosage | 1 | 2008 | 26 | 0.020 |
Why?
| | Gene Amplification | 1 | 2008 | 29 | 0.020 |
Why?
| | Gene Deletion | 1 | 2008 | 57 | 0.020 |
Why?
| | Male | 1 | 2006 | 17153 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2009 | 467 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2008 | 232 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2007 | 146 | 0.020 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2007 | 131 | 0.020 |
Why?
| | Prognosis | 1 | 2008 | 1025 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2008 | 3303 | 0.010 |
Why?
|
|
Rao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|